Edinger M, Sweeney T J, Tucker A A, Olomu A B, Negrin R S, Contag C H
Department of Medicine, Stanford University School of Medicine, CA 94305-5623, USA.
Neoplasia. 1999 Oct;1(4):303-10. doi: 10.1038/sj.neo.7900048.
Revealing the mechanisms of neoplastic disease and enhancing our ability to intervene in these processes requires an increased understanding of cellular and molecular changes as they occur in intact living animal models. We have begun to address these needs by developing a method of labeling tumor cells through constitutive expression of an optical reporter gene, and noninvasively monitoring cellular proliferation in vivo using a sensitive photon detection system. A stable line of HeLa cells that expressed a modified firefly luciferase gene was generated, and proliferation of these cells in irradiated severe combined immunodeficiency (SCID) mice was monitored. Tumor cells were introduced into animals via subcutaneous, intraperitoneal and intravenous inoculation and whole body images, that revealed tumor location and growth kinetics, were obtained. The number of photons that were emitted from the labeled tumor cells and transmitted through murine tissues was sufficient to detect 1x10(3) cells in the peritoneal cavity, 1x10(4) cells at subcutaneous sites and 1x10(6) circulating cells immediately following injection. The kinetics of cell proliferation, as measured by photon emission, was exponential in the peritoneal cavity and at subcutaneous sites. Intravenous inoculation resulted in detectable colonies of tumor cells in animals receiving more than 1x10(6) cells. Our demonstrated ability to detect small numbers of tumor cells in living animals noninvasively suggests that therapies designed to treat minimal disease states, as occur early in the disease course and after elimination of the tumor mass, may be monitored using this approach. Moreover, it may be possible to monitor micrometastases and evaluate the molecular steps in the metastatic process. Spatiotemporal analyses of neoplasia will improve the predictability of animal models of human disease as study groups can be followed over time, and this method will accelerate development of novel therapeutic strategies.
揭示肿瘤性疾病的机制并增强我们干预这些过程的能力,需要更深入地了解完整活体动物模型中发生的细胞和分子变化。我们已开始通过开发一种方法来满足这些需求,即通过组成型表达光学报告基因来标记肿瘤细胞,并使用灵敏的光子检测系统在体内无创监测细胞增殖。我们构建了一个稳定表达修饰型萤火虫荧光素酶基因的HeLa细胞系,并监测了这些细胞在受辐照的严重联合免疫缺陷(SCID)小鼠体内的增殖情况。通过皮下、腹腔和静脉接种将肿瘤细胞引入动物体内,并获取了显示肿瘤位置和生长动力学的全身图像。标记的肿瘤细胞发出并透过小鼠组织的光子数量足以在注射后立即检测到腹腔内1x10(3)个细胞、皮下部位1x10(4)个细胞以及循环中的1x10(6)个细胞。通过光子发射测量的细胞增殖动力学在腹腔和皮下部位呈指数增长。静脉接种导致接受超过1x10(6)个细胞的动物体内出现可检测到的肿瘤细胞集落。我们已证明能够在活体动物中无创检测少量肿瘤细胞,这表明可使用这种方法监测旨在治疗疾病早期和肿瘤块消除后出现的微小疾病状态的疗法。此外,有可能监测微转移并评估转移过程中的分子步骤。肿瘤形成的时空分析将提高人类疾病动物模型的可预测性,因为可以随时间跟踪研究组,并且这种方法将加速新型治疗策略的开发。